Clinical trial
Randomised, Double-blind, Placebo-controlled Phase III Trial to Determine the Efficacy and Safety of a Standardised Oral Extract of Cannabis Sativa for the Symptomatic Relief of Muscle Stiffness and Pain in Multiple Sclerosis.
NCT00552604 is registered in ClinicalTrials.gov with Institut fur Klinische Forschung, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised, Double-blind, Placebo-controlled Phase III Trial to Determine the Efficacy and Safety of a Standardised Oral Extract of Cannabis Sativa for the Symptomatic Relief of Muscle Stiffness and Pain in Multiple Sclerosis.
- Lead sponsor
- Institut fur Klinische Forschung, Germany
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- June 30, 2006
- Completion date
- November 30, 2008
- Enrollment
- 279 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.